# Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy

> **NCT01995786** · NA · COMPLETED · sponsor: **Regina Elena Cancer Institute** · enrollment: 200 (actual)

## Conditions studied

- Postoperative Complications

## Interventions

- **DEVICE:** Goal Directed Fluid Therapy FloTrac/Vigileo

## Key facts

- **NCT ID:** NCT01995786
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01995786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01995786, "Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01995786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*